Related Experiment Video
Updated: Jun 2, 2026

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa
Published on: February 17, 2014
Is Ciprofloxacin a Substrate of P-glycoprotein?
Abstract:
INTRODUCTION: Studies using MDCKII and LLC-PK1 cells transfected with MDR1 cDNA indicate that ciprofloxacin is not a substrate of P-glycoprotein. However, our data has shown that transport studies done using different P-gp overexpressing cell lines (MDCKI-MDR1, MDCKII-MDR1 and L-MDR1), could lead to contradictory conclusion on whether a compound is a substrate of P-gp. The aim of our study was to determine if ciprofloxacin is indeed not a P-glycoprotein substrate using MDCKI cells transfected with human MDR1 cDNA. METHODS: Semi-quantitative RT-PCR was used to determine the mRNA level of MDR1 while Western blot was performed to determine the protein expression level of P-gp, MRP1 and MRP2 in various cells. Ciprofloxacin bidirectional transport studies were performed in MDCKI, MDCKI-MDR1, MDCKII, MDCKII-MDR1, MDCKII-MRP2, LLC-PK1, L-MRP1 and L-MDR1 cells. RESULTS: Ciprofloxacin showed net secretion in MDCKI-MDR1 but net absorption in MDCKI cells. Various P-gp inhibitors decreased the B to A and increased the A to B transport of ciprofloxacin in MDCKI-MDR1 cells while having no effect in MDCKI cells. The B to A transport of ciprofloxacin in MDCKI-MDR1 cells was not affected by non-P-gp inhibitors. In the presence of indomethacin, ciprofloxacin showed net secretion instead of net absorption in MDCKI cells while in the presence of probenecid and sulfinpyrazone, there was no net secretion and absorption. There was no difference in ciprofloxacin transport between MDCKII and MDCKII-MDR1, LLC-PK1 and L-MDR1, LLC-PK1 and L-MRP1 and MDCKII and MDCKII-MRP2. CONCLUSIONS: Transport data in MDCKI and MDCKI-MDR1 cells indicate that ciprofloxacin is a substrate of P-gp but data from MDCKII, MDCKII-MDR1, LLC-PK1 and L-MDR1 cells indicate that ciprofloxacin is not a substrate of P-gp. Vinblastine, a well-known P-gp substrate, also did not show differences between LLC-PK1 and L-MDR1 cells. Further studies need to be performed to characterize these P-gp overexpressing cell lines and the transport of ciprofloxacin.
Insights
Ciprofloxacin transport varies depending on the cell line used, indicating it is a P-glycoprotein substrate in some models but not others. Further characterization of P-glycoprotein overexpressing cell lines is needed.
Area of Science:
- Pharmacokinetics and Drug Transport
- Cell Biology
- Molecular Pharmacology
Background:
- Previous studies suggest ciprofloxacin is not a substrate of P-glycoprotein (P-gp).
- However, contradictory results arise from transport studies using different P-gp overexpressing cell lines.
- This highlights the need for careful cell line characterization in drug transport studies.
Purpose of the Study:
- To investigate whether ciprofloxacin is a substrate of P-glycoprotein (P-gp).
- To evaluate ciprofloxacin transport in MDCKI cells transfected with human MDR1 cDNA.
- To reconcile conflicting data on ciprofloxacin's interaction with P-gp.
Main Methods:
- Semi-quantitative RT-PCR to assess MDR1 mRNA levels.
- Western blot analysis for P-gp, MRP1, and MRP2 protein expression.
- Bidirectional transport assays of ciprofloxacin across various cell monolayers (MDCKI, MDCKI-MDR1, MDCKII, MDCKII-MDR1, MDCKII-MRP2, LLC-PK1, L-MRP1, L-MDR1).
Main Results:
- Ciprofloxacin exhibited net secretion in MDCKI-MDR1 cells but net absorption in MDCKI cells.
- P-gp inhibitors modulated ciprofloxacin transport in MDCKI-MDR1 cells, consistent with P-gp substrate activity.
- No significant differences in ciprofloxacin transport were observed between MDCKII/MDCKII-MDR1, LLC-PK1/L-MDR1, LLC-PK1/L-MRP1, and MDCKII/MDCKII-MRP2 cell pairs.
Conclusions:
- Transport data in MDCKI and MDCKI-MDR1 cells suggest ciprofloxacin is a P-gp substrate.
- Conversely, data from MDCKII, LLC-PK1, and derived cell lines indicate ciprofloxacin is not a P-gp substrate.
- Discrepancies necessitate further characterization of P-gp overexpressing cell lines and ciprofloxacin transport mechanisms.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacokinetics: Drug–Drug Interactions
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Inhibitors of Bacterial DNA Synthesis
Hepatic Drug Clearance: Role of Transporters
